MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Spatial distribution of Parkinson’s disease in the Canton of Geneva, Switzerland

V. Fleury, R. Himsl, S. Joost, N. Nicastro, I. Guessous, P. Burkhard (Lausanne, Switzerland)

Meeting: 2019 International Congress

Abstract Number: 1805

Keywords: Environmental toxins, Parkinsonism

Session Information

Date: Wednesday, September 25, 2019

Session Title: Epidemiology

Session Time: 1:15pm-2:45pm

Location: Les Muses, Level 3

Objective: The objective of the study was to determine whether PD prevalence exhibit any spatial dependence in order to get hypothesis on PD risk or protective factors.

Background: The cause of PD is unknown. Studying its spatial distribution could provide indication on its pathogenesis.

Method: An extensive case-finding approach was used to find PD cases in the Canton of Geneva. Controls were derived from a sample of geolocated individuals sourced from an ongoing cross-sectional population-based study used to control for the variable population density across the canton, and from a comprehensive population census dataset used to adjust for demographic and socio-economic confounders. All individuals were geolocalized. Age, gender, ethnicity and socioeconomical status were chosen as confounding variables. A logistic mixed-effect model with a random intercept was fit to the populational dataset in order to control for confounding variables. Unit-level statistics were transformed into individual-level data. Getis-Ord Gi* statistics were computed to identify hotspots and coldspots of disease prevalence. Hot- and cold-spots were compared to maps illustrating the spatial distributions of pesticide-associated landcovers, atmospheric pollution and water supply. The results were compared with those obtained with the more commonly used aggregation method.

Results: A total of 1,115 patients were compared with 12,614 geolocated controls and were adjusted for confounders with 474,211 individuals from the census dataset. Individual-level method revealed 5 PD hotspots and 8 PD coldspots. Coldspots were preferentially located in the peripheries of the Canton apart from one centrally located. Hotspots were concentrated into three major clusters near the lake. After adjustment for confounders, clusters shrank drastically but persisted, implying that some external, spatially-dependent factor may impact disease risk. Hotspots did not match with high pesticide exposure, high atmospheric pollution levels and source of water supply. PD spatial distribution obtained with the individual-method was surprisingly different than the one obtained with the aggregation method.

Conclusion: Our study points out a spatial dependence of PD with clusters of high and low prevalence in the canton of Geneva. The clusters did not conform to the dichotomous rural or urban dominance that is sometimes reported in the literature.

To cite this abstract in AMA style:

V. Fleury, R. Himsl, S. Joost, N. Nicastro, I. Guessous, P. Burkhard. Spatial distribution of Parkinson’s disease in the Canton of Geneva, Switzerland [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/spatial-distribution-of-parkinsons-disease-in-the-canton-of-geneva-switzerland/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/spatial-distribution-of-parkinsons-disease-in-the-canton-of-geneva-switzerland/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley